Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Licenses Microarray Technology to PathWork for Cancer Dx

NEW YORK, Nov. 1 (GenomeWeb News) - Affymetrix has granted PathWork Informatics long-term non-exclusive access to its microarray technology to develop and market in vitro diagnostics for cancer.


Under the terms of the agreement, PathWork has the right to use Affymetrix's technology to develop tests for tumors of unknown origin, as well as other cancer tests, Affy said. PathWork will incorporate Affymetrix arrays into PathWorks Oncology Suites, the company's diagnostic kits that are currently under development.


Financial terms of the agreement were not disclosed.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.